Effect of exogenous recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor on neutrophil function following allogeneic bone marrow transplantation
- PMID: 1716591
Effect of exogenous recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor on neutrophil function following allogeneic bone marrow transplantation
Abstract
Functional activity of peripheral blood granulocytes was assessed in seven patients and in their normal donors following allogeneic bone marrow transplantation (BMT). Functions studied included superoxide generation (O2-), intracellular killing of Staphylococcus aureus, phagocytosis, and killing of Candida albicans. Neutrophils were tested following preincubation with 300 pM granulocyte-macrophage colony-stimulating factor (GM-CSF), 1.2 nM granulocyte colony-stimulating factor (G-CSF), or buffered solution (diluent) as control. Our data indicate that following BMT, both recipients and their normal donors show GM-CSF- and G-CSF-induced increases in: 1) O2- production in response to fMet-Leu-Phe (fMLP), 2) killing of S. aureus, and 3) phagocytosis of C. albicans. In two patients that showed low candidacidal activity, GM-CSF and G-CSF markedly enhanced the cytotoxic activity of the cells. Our studies indicate that GM-CSF and G-CSF increase "oxygen-dependent" oxidative activities in neutrophils from BMT recipients and their normal donors and enhance the antimicrobial activity of the cells.
Similar articles
-
Increased respiratory burst activity of neutrophils in patients with aplastic anemia: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.Exp Hematol. 1992 Oct;20(9):1090-3. Exp Hematol. 1992. PMID: 1281785
-
Effects of recombinant human granulocyte and granulocyte-macrophage colony-stimulating factors on neutrophil function following autologous bone marrow transplantation.Leuk Res. 1991;15(12):1175-82. doi: 10.1016/0145-2126(91)90187-x. Leuk Res. 1991. PMID: 1722549
-
Recombinant human G-CSF and GM-CSF prime human neutrophils for superoxide production through different signal transduction mechanisms.J Lab Clin Med. 1991 Dec;118(6):576-84. J Lab Clin Med. 1991. PMID: 1720802
-
Lymphokines: enhancement by granulocyte-macrophage and granulocyte colony-stimulating factors of neonatal myeloid kinetics and functional activation of polymorphonuclear leukocytes.Rev Infect Dis. 1990 May-Jun;12 Suppl 4:S492-7. doi: 10.1093/clinids/12.supplement_4.s492. Rev Infect Dis. 1990. PMID: 1694596 Review.
-
[Current data on GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) in acute myeloid leukemia].Bull Cancer. 1992;79(2):123-31. Bull Cancer. 1992. PMID: 1392151 Review. French.
Cited by
-
Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection.Virulence. 2016 Nov 16;7(8):901-916. doi: 10.1080/21505594.2016.1208866. Epub 2016 Jul 6. Virulence. 2016. PMID: 27385018 Free PMC article. Review.
-
A kindred with Griscelli disease: spectrum of neurological involvement.Eur J Pediatr. 1993 May;152(5):402-5. doi: 10.1007/BF01955897. Eur J Pediatr. 1993. PMID: 8319705
-
Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.Drugs. 1992 Apr;43(4):516-560. doi: 10.2165/00003495-199243040-00008. Drugs. 1992. PMID: 28421558
-
Combined effect of human neutrophils, ceftazidime and granulocyte colony-stimulating factor on killing of Escherichia coli.Eur J Clin Microbiol Infect Dis. 1995 Jun;14(6):536-9. doi: 10.1007/BF02113435. Eur J Clin Microbiol Infect Dis. 1995. PMID: 7588830
-
Synergy of simultaneous administration of ofloxacin and granulocyte colony-stimulating factor in killing of Escherichia coli by human neutrophils.Infection. 1995 Sep-Oct;23(5):298-300. doi: 10.1007/BF01716290. Infection. 1995. PMID: 8557389
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials